CLASS II ONGOING Drug recall · Reported 27 May 2026 · FDA Enforcement Report

Estradiol Gel, 0.1%, 0.25 mg per packet, 30 packets recalled

ANI Pharmaceuticals is recalling Estradiol Gel, 0.1%, 0.25 mg per packet, 30 packets per, distributed nationwide in the US. The recall was initiated on 12 May 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot M251109, exp Nov 2027
NDC70954-530, 70954-531, 70954-532, 70954-533, 70954-534
UPC0370954531104, 0370954530107, 0370954532101, 0370954534105, 0370954533108
Quantity recalled3964 Cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0543-2026
FDA event ID
98947
Recalling firm
ANI Pharmaceuticals, Baudette, MN
Manufacturer
ANI Pharmaceuticals, Inc.
Classification
Class II
Status
Ongoing
Recall initiated
12 May 2026
FDA classified
20 May 2026
Reported
27 May 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

12 May 2026Recall initiated by company
20 May 2026Classified by FDA+8 days
27 May 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Container; packets were found to be either empty or partially full.

Product as listed by the FDA

Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC 70954-531-20

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Defective Container; packets were found to be either empty or partially full.

Which lots are affected?

Lot M251109, exp Nov 2027

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from ANI Pharmaceuticals

All 13

Other Estradiol recalls

All 71